Ratings by Stifel (Derek C. Archila)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/1/2021 Immunovant IMVT Downgrade Hold
(Buy)
15.16
(26.66)
75.86% Details
5/10/2021 Galapagos NV GLPG Maintain Hold
(N/A)
 
 
  Details
5/6/2021 Intercept Pharmaceuticals ICPT Maintain Hold
(N/A)
 
 
  Details
5/6/2021 Madrigal Pharmaceuticals MDGL Maintain Hold
(N/A)
 
 
  Details
3/11/2021 Selecta Biosciences SELB Maintain Hold
(N/A)
 
 
  Details
2/25/2021 Amarin Corporation AMRN Maintain Hold
(N/A)
 
 
  Details
2/16/2021 Immunovant IMVT Maintain Buy
(N/A)
 
 
  Details
10/29/2020 Alexion Pharmaceuticals ALXN Maintain Hold
(N/A)
 
 
  Details
10/16/2020 Galapagos NV GLPG Maintain Hold
(N/A)
 
 
  Details
9/3/2020 Amarin Corporation AMRN Maintain Hold
(N/A)
 
 
  Details
8/20/2020 Principia Biopharma PRNB Downgrade Hold
(Buy)
99.61
(100.05)
0.44% Details
8/19/2020 Galapagos NV GLPG Maintain Hold
(N/A)
 
 
  Details
8/10/2020 Intercept Pharmaceuticals ICPT Maintain Hold
(N/A)
 
 
  Details
8/7/2020 Principia Biopharma PRNB Maintain Buy
(N/A)
 
 
  Details
8/7/2020 Galapagos NV GLPG Maintain Hold
(N/A)
 
 
  Details
8/3/2020 CymaBay Therapeutic CBAY Maintain Buy
(N/A)
 
 
  Details
6/29/2020 Intercept Pharmaceuticals ICPT Maintain Hold
(N/A)
 
 
  Details
5/26/2020 Intercept Pharmaceuticals ICPT Maintain Hold
(N/A)
 
 
  Details
5/12/2020 Intercept Pharmaceuticals ICPT Maintain Hold
(N/A)
 
 
  Details
2/27/2020 Madrigal Pharmaceuticals MDGL Maintain Hold
(N/A)
 
 
  Details
2/27/2020 Intercept Pharmaceuticals ICPT Maintain Hold
(N/A)
 
 
  Details
12/19/2019 Principia Biopharma PRNB Maintain Buy
(N/A)
 
 
  Details
11/25/2019 Intercept Pharmaceuticals ICPT Maintain Hold
(N/A)
 
 
  Details
10/10/2019 Principia Biopharma PRNB Maintain Buy
(N/A)
 
 
  Details